Grant: Operating Grant
McGill University
$60,000.00
Incidence, symptoms and impact of flare in patients with early rheumatoid arthritis: Insights from the Canadian early ArThritis CoHort(CATCH)
EF 2013-14
Résumé
Our goal is to learn about rheumatoid arthritis (RA) flares. Flares may lead to increased and disability in RA and they are a significant risk when RA medications are reduced or new medicines are tested. Though flares are common, little is known on this topic. Flares are important to study because if they do lead to poor outcomes, new strategies may be needed to identify and treat flares quickly. By reducing the number/severity of flares, we can ultimately improve the lives of people with RA.
This project uniquely combines information about flares from both RA patients and their doctors. CATCH (the Canadian early Arthritis Cohort) is one of the largest studies of early RA in the world; patients are seen every 3-6 months at 19 Canadian centers. At each visit, patient's complete questionnaires about how they feel and how their RA is affecting their lives; their doctor also provides detailed health and RA information. In late 2011, participants began completing a new questionnaire at each visit asking whether they think their RA is flaring; people who think they are in a flare also rate intensity, describe their symptoms and impact on everyday life, and what they do to self-manage it. We now have >2200 participants seen up to 8 times. Early results suggest > 30% are having a serious flare during at least 1 visit (far more than anticipated) and most often their doctors agree they are in a flare.
This study will provide important new information about RA flares from two sources. From patients, we will learn about how often they believe they are having a serious RA flare, their symptoms, impact of quality of life, self-management strategies, and whether flares differ in men and women. From the doctors, we can learn how often patients and doctors agree the patient is in a serious flare, how flares are related to changes in treatment, how flares are usually treated and how flares may affect long-term outcomes such as disability and disease progression.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
292078
Name
Bartlett Susan J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Incidence, symptoms and impact of flare in patients with early rheumatoid arthritis: Insights from the Canadian early ArThritis CoHort(CATCH)
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Disability; Disease Progression; Flares; Health Outcomes; Patient-Reported Outcomes; Rheumatoid Arthritis
Abstract
Our goal is to learn about rheumatoid arthritis (RA) flares. Flares may lead to increased and disability in RA and they are a significant risk when RA medications are reduced or new medicines are tested. Though flares are common, little is known on this topic. Flares are important to study because if they do lead to poor outcomes, new strategies may be needed to identify and treat flares quickly. By reducing the number/severity of flares, we can ultimately improve the lives of people with RA.
This project uniquely combines information about flares from both RA patients and their doctors. CATCH (the Canadian early Arthritis Cohort) is one of the largest studies of early RA in the world; patients are seen every 3-6 months at 19 Canadian centers. At each visit, patient's complete questionnaires about how they feel and how their RA is affecting their lives; their doctor also provides detailed health and RA information. In late 2011, participants began completing a new questionnaire at each visit asking whether they think their RA is flaring; people who think they are in a flare also rate intensity, describe their symptoms and impact on everyday life, and what they do to self-manage it. We now have >2200 participants seen up to 8 times. Early results suggest > 30% are having a serious flare during at least 1 visit (far more than anticipated) and most often their doctors agree they are in a flare.
This study will provide important new information about RA flares from two sources. From patients, we will learn about how often they believe they are having a serious RA flare, their symptoms, impact of quality of life, self-management strategies, and whether flares differ in men and women. From the doctors, we can learn how often patients and doctors agree the patient is in a serious flare, how flares are related to changes in treatment, how flares are usually treated and how flares may affect long-term outcomes such as disability and disease progression.
Competitiondate
201309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bartlett, Susan J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $60,000~ $0~